These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19531426)

  • 1. Drug treatment of oral submucous fibrosis: a review of the literature.
    Jiang X; Hu J
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1510-5. PubMed ID: 19531426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of drug treatment of oral submucous fibrosis.
    Chole RH; Gondivkar SM; Gadbail AR; Balsaraf S; Chaudhary S; Dhore SV; Ghonmode S; Balwani S; Mankar M; Tiwari M; Parikh RV
    Oral Oncol; 2012 May; 48(5):393-8. PubMed ID: 22206808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment for oral submucous fibrosis.
    Angadi PV
    Evid Based Dent; 2010; 11(2):56. PubMed ID: 20577289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of medicinal interventions for the management of oral submucous fibrosis: a systematic review of the literature.
    Awan KH; Patil S; Habib SR; Pejcic A; Zain RB
    J Contemp Dent Pract; 2014 Nov; 15(6):812-7. PubMed ID: 25825114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lycopene in the management of oral submucous fibrosis.
    Kumar A; Bagewadi A; Keluskar V; Singh M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):207-13. PubMed ID: 17234537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
    Vedeswari CP; Jayachandran S; Ganesan S
    Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function.
    Lin HJ; Lin JC
    Oral Dis; 2007 Jul; 13(4):407-13. PubMed ID: 17577328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature.
    Scales CD; Norris RD; Preminger GM; Vieweg J; Peterson BL; Dahm P
    J Urol; 2008 Oct; 180(4):1463-7. PubMed ID: 18710745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting of harm in randomized controlled trials published in the urological literature.
    Breau RH; Gaboury I; Scales CD; Fesperman SF; Watterson JD; Dahm P
    J Urol; 2010 May; 183(5):1693-7. PubMed ID: 20299044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of trigeminal neuralgia: a systematic review of the literature.
    Chole R; Patil R; Degwekar SS; Bhowate RR
    J Oral Maxillofac Surg; 2007 Jan; 65(1):40-5. PubMed ID: 17174762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: A meta-analysis of randomized controlled clinical trials.
    Guo J; Xie H; Mao S; Liang M; Wu H
    J Oral Pathol Med; 2020 Apr; 49(4):311-319. PubMed ID: 32145110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis: A meta-analysis.
    Liu J; Chen F; Wei Z; Qiu M; Li Z; Dan H; Chen Q; Jiang L
    Oral Dis; 2018 Jul; 24(5):706-716. PubMed ID: 28737007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allicin as a possible adjunctive therapeutic drug for stage II oral submucous fibrosis: a preliminary clinical trial in a Chinese cohort.
    Jiang X; Zhang Y; Li F; Zhu Y; Chen Y; Yang S; Sun G
    Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1540-6. PubMed ID: 26165773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral submucous fibrosis--treatment with hyalase.
    Kakar PK; Puri RK; Venkatachalam VP
    J Laryngol Otol; 1985 Jan; 99(1):57-9. PubMed ID: 3968475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.
    Bhadage CJ; Umarji HR; Shah K; Välimaa H
    Clin Oral Investig; 2013 Jun; 17(5):1375-82. PubMed ID: 22893038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases.
    Lai DR; Chen HR; Lin LM; Huang YL; Tsai CC
    J Oral Pathol Med; 1995 Oct; 24(9):402-6. PubMed ID: 8537913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of medicinal interventions for oral submucous fibrosis: A network meta-analysis.
    Rai A; Shrivastava PK; Kumar A; Kumar A; Prasad K; Shakeel S; Ul Haque Z
    J Stomatol Oral Maxillofac Surg; 2023 Jun; 124(3):101423. PubMed ID: 36781110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of oral lycopene in the management of oral submucous fibrosis.
    Kerr AR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):214-5. PubMed ID: 17234538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.